Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-05-04 Purchase |
2023-05-08 9:15 pm |
REPLIGEN CORP | RGEN | Madaus Martin D Director |
1,500 | $158.84 | $238,260 | 1,622 (Indirect Direct) |
View |
2023-02-16 Sale |
2023-02-17 4:56 pm |
REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer |
5,647 | $200 | $1,129,400 | 29,325 (Direct) |
View |
2022-03-16 Purchase |
2022-12-15 06:55 am |
REPLIGEN CORP | RGEN | EGLINTON MANNER CARRIE Director |
625 | $175.02 | $109,388 | 2,106 (Direct) |
View |
2022-11-11 Sale |
2022-11-14 5:43 pm |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
25,000 | $200 | $5,000,000 | 212,511 (Direct) |
View |
2022-09-09 Sale |
2022-09-09 4:14 pm |
REPLIGEN CORP | RGEN | DAWES KAREN A Director |
775 | $227.17 | $176,057 | 76,401 (Direct) |
View |
2022-09-08 Sale |
2022-09-09 4:14 pm |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
26,402 | $224.73 | $5,933,438 | 237,511 (Direct) |
View |
2022-08-16 Sale |
2022-08-17 4:41 pm |
REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer |
6,698 | $252.86 | $1,693,689 | 37,970 (Direct) |
View |
2022-08-11 Sale |
2022-08-12 4:49 pm |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
4,840 | $254.32 | $1,230,886 | 19,670 (Direct) |
View |
2022-08-04 Sale |
2022-08-05 4:29 pm |
REPLIGEN CORP | RGEN | Gebski Christine See Remarks |
3,357 | $243.01 | $815,785 | 30,735 (Direct) |
View |
2022-08-03 Sale |
2022-08-04 4:32 pm |
REPLIGEN CORP | RGEN | Bylund James Chief Operating Officer |
2,000 | $240.4 | $480,800 | 17,733 (Direct) |
View |
2022-08-01 Sale |
2022-08-02 5:26 pm |
REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer |
2,000 | $220 | $440,000 | 37,187 (Direct) |
View |
2022-07-21 Sale |
2022-07-22 4:25 pm |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
24,802 | $200 | $4,960,400 | 263,913 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2023-05-18 Option Award |
2023-05-22 9:26 pm |
2024-05-18 2033-05-18 |
REPLIGEN CORP | RGEN | DAWES KAREN A Director |
2,528 | $0 | 78,929 (Direct) |
View |
2023-05-18 Option Award |
2023-05-22 9:25 pm |
2024-05-18 2033-05-18 |
REPLIGEN CORP | RGEN | EGLINTON MANNER CARRIE Director |
2,173 | $0 | 3,654 (Direct) |
View |
2023-05-18 Option Award |
2023-05-22 9:21 pm |
2024-05-18 2033-05-18 |
REPLIGEN CORP | RGEN | BARTHELEMY NICOLAS Director |
2,173 | $0 | 4,254 (Direct) |
View |
2023-05-18 Option Award |
2023-05-22 9:21 pm |
2024-05-18 2033-05-18 |
REPLIGEN CORP | RGEN | MUIR GLENN P Director |
2,173 | $0 | 9,069 (Direct) |
View |
2023-05-18 Option Award |
2023-05-22 9:19 pm |
2024-05-18 2033-05-18 |
REPLIGEN CORP | RGEN | Konstantinov Konstantin Director |
2,173 | $0 | 2,707 (Direct) |
View |
2023-05-16 Tax Withholding |
2023-05-16 7:01 pm |
N/A N/A |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
710 | $154.03 | 23,556 (Direct) |
View |
2023-05-16 Tax Withholding |
2023-05-16 7:00 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Gebski Christine See Remarks |
334 | $154.03 | 32,575 (Direct) |
View |
2023-05-16 Tax Withholding |
2023-05-16 7:00 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer |
710 | $154.03 | 37,381 (Direct) |
View |
2023-03-24 Acquisition |
2023-05-08 9:15 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Madaus Martin D Director |
11 | $186.22 | 1,622 (Indirect) |
View |
Ownership(A) |
2023-05-05 5:25 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Madaus Martin D Director |
0 | $0 | 2 (Indirect) |
View |
2023-04-04 Tax Withholding |
2023-04-04 9:37 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Bylund James Chief Operating Officer |
334 | $163.45 | 17,568 (Direct) |
View |
2023-03-03 Tax Withholding |
2023-03-06 5:33 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer |
3,674 | $188 | 43,110 (Direct) |
View |
2023-03-02 Option Award |
2023-03-06 5:33 pm |
N/A 2033-03-02 |
REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer |
18,662 | $0 | 43,110 (Direct) |
View |
2023-03-03 Tax Withholding |
2023-03-06 5:31 pm |
N/A N/A |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
1,247 | $188 | 27,857 (Direct) |
View |
2023-03-02 Option Award |
2023-03-06 5:31 pm |
N/A 2033-03-02 |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
10,650 | $0 | 27,857 (Direct) |
View |
2023-03-03 Tax Withholding |
2023-03-06 5:28 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Gebski Christine See Remarks |
126 | $188 | 36,499 (Direct) |
View |
2023-03-02 Option Award |
2023-03-06 5:28 pm |
N/A 2033-03-02 |
REPLIGEN CORP | RGEN | Gebski Christine See Remarks |
7,432 | $0 | 36,499 (Direct) |
View |
2023-03-03 Tax Withholding |
2023-03-06 5:23 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
8,244 | $188 | 215,387 (Direct) |
View |
2023-03-02 Option Award |
2023-03-06 5:23 pm |
N/A 2033-03-02 |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
58,057 | $0 | 215,387 (Direct) |
View |
2023-03-03 Tax Withholding |
2023-03-06 5:13 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Bylund James Chief Operating Officer |
210 | $188 | 26,546 (Direct) |
View |
2023-03-02 Option Award |
2023-03-06 5:13 pm |
N/A 2033-03-02 |
REPLIGEN CORP | RGEN | Bylund James Chief Operating Officer |
17,617 | $0 | 26,546 (Direct) |
View |
2023-02-28 Tax Withholding |
2023-03-02 7:47 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
2,748 | $173.28 | 165,574 (Direct) |
View |
2023-03-02 Tax Withholding |
2023-03-02 7:47 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
6,670 | $176.37 | 165,574 (Direct) |
View |
2023-03-02 Tax Withholding |
2023-03-02 5:55 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Gebski Christine See Remarks |
630 | $174.37 | 29,193 (Direct) |
View |
2023-02-28 Tax Withholding |
2023-03-02 5:55 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Gebski Christine See Remarks |
460 | $173.28 | 29,193 (Direct) |
View |
2023-02-28 Tax Withholding |
2023-03-01 5:32 pm |
N/A N/A |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
358 | $173.28 | 18,454 (Direct) |
View |
2023-02-28 Tax Withholding |
2023-03-01 5:22 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer |
521 | $173.28 | 28,122 (Direct) |
View |
2023-02-28 Tax Withholding |
2023-02-28 7:54 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Bylund James Chief Operating Officer |
594 | $173.44 | 9,139 (Direct) |
View |
2023-02-28 Tax Withholding |
2023-02-28 7:53 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
3,273 | $173.44 | 174,992 (Direct) |
View |
2023-02-28 Tax Withholding |
2023-02-28 7:53 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer |
682 | $173.44 | 28,643 (Direct) |
View |
2023-02-28 Tax Withholding |
2023-02-28 7:46 pm |
N/A N/A |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
458 | $173.44 | 18,812 (Direct) |
View |
2023-02-28 Tax Withholding |
2023-02-28 7:46 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Gebski Christine See Remarks |
452 | $173.44 | 30,283 (Direct) |
View |
2023-02-06 Option Award |
2023-02-08 7:24 pm |
2023-05-18 2033-02-06 |
REPLIGEN CORP | RGEN | Madaus Martin D Director |
2,169 | $0 | 2,169 (Direct) |
View |
2022-11-11 Exercise |
2022-11-14 5:43 pm |
N/A 2028-02-29 |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
25,000 | $0 | 212,511 (Direct) |
View |
2022-11-11 Exercise |
2022-11-14 5:43 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
25,000 | $33.87 | 212,511 (Direct) |
View |
2022-10-07 Exercise |
2022-10-11 5:00 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer |
466 | $59.52 | 37,080 (Direct) |
View |
2022-10-07 Exercise |
2022-10-11 5:00 pm |
N/A 2029-02-28 |
REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer |
466 | $0 | 37,080 (Direct) |
View |
2022-09-08 Exercise |
2022-09-09 4:14 pm |
N/A 2028-02-29 |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
10,000 | $0 | 237,511 (Direct) |
View |
2022-09-08 Exercise |
2022-09-09 4:14 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
10,000 | $33.87 | 237,511 (Direct) |
View |
2022-08-16 Exercise |
2022-08-17 4:41 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer |
3,047 | $86.1 | 37,970 (Direct) |
View |
2022-08-16 Exercise |
2022-08-17 4:41 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer |
970 | $215.58 | 37,970 (Direct) |
View |
2022-08-16 Exercise |
2022-08-17 4:41 pm |
N/A 2030-02-27 |
REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer |
4,017 | $0 | 37,970 (Direct) |
View |
2022-08-11 Exercise |
2022-08-12 4:49 pm |
N/A N/A |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
646 | $86.1 | 19,670 (Direct) |
View |
2022-08-11 Exercise |
2022-08-12 4:49 pm |
N/A N/A |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
2,000 | $33.05 | 19,670 (Direct) |
View |
2022-08-11 Exercise |
2022-08-12 4:49 pm |
N/A N/A |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
1,354 | $59.52 | 19,670 (Direct) |
View |
2022-08-11 Exercise |
2022-08-12 4:49 pm |
N/A 2026-12-14 |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
4,000 | $0 | 19,670 (Direct) |
View |
2022-08-03 Exercise |
2022-08-04 4:32 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Bylund James Chief Operating Officer |
2,000 | $94.33 | 17,733 (Direct) |
View |
2022-08-03 Exercise |
2022-08-04 4:32 pm |
N/A 2030-04-01 |
REPLIGEN CORP | RGEN | Bylund James Chief Operating Officer |
2,000 | $0 | 17,733 (Direct) |
View |
2022-07-21 Exercise |
2022-07-22 4:25 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
15,154 | $32.4 | 263,913 (Direct) |
View |
2022-07-21 Exercise |
2022-07-22 4:25 pm |
N/A 2028-02-29 |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
20,154 | $0 | 263,913 (Direct) |
View |
2022-07-21 Exercise |
2022-07-22 4:25 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
5,000 | $33.87 | 263,913 (Direct) |
View |
2022-05-26 Option Award |
2022-05-31 8:25 pm |
2023-05-26 2032-05-26 |
REPLIGEN CORP | RGEN | Mhatre Rohin Director |
4,122 | $0 | 4,579 (Direct) |
View |